The Kansas City Royals have made a surprising move by signing right-hander Tony Gonsolin to a major league deal for the 2026 season, with a club option for 2027. This decision comes after Gonsolin's tumultuous journey through the past few years, marked by injuries and inconsistent performance. What makes this deal even more intriguing is the Royals' decision to place Gonsolin on the 15-day injured list immediately upon signing, suggesting they are taking a calculated risk on his health and potential. This move also opens a 40-man spot, leading to the designation of fellow righty Eli Morgan for assignment.
Gonsolin, 32, had a brief but impressive stint with the Los Angeles Dodgers from 2019 to 2022. During this period, he pitched 572 2/3 innings across 59 appearances, with 51 of those being starts. His ERA of 2.51 during this time was impressive, but it was likely aided by lucky factors such as a .223 batting average on balls in play and an 81.3% strand rate. Despite this, his 24.8% strikeout rate and 8.5% walk rate were above average, and ERA estimators like FIP and SIERA suggested he was more of a solid mid-rotation or back-end starter rather than an ace.
However, Gonsolin's career took a turn for the worse in 2023 due to a left ankle sprain and forearm inflammation, which led to him being placed on the injured list. This resulted in only 20 starts that year, with a significantly higher ERA of 4.98. The situation worsened when he underwent Tommy John surgery in August 2023, causing him to miss the entire 2024 season, except for a few minor league rehab outings in September. The Royals' decision to sign him despite his recent struggles and surgeries is a bold move, one that could pay off if he can regain his form from his Dodgers days.
The Royals' strategy with Gonsolin is a testament to their willingness to take risks and believe in second chances. It also highlights the team's commitment to building a competitive roster, even if it means dealing with the uncertainties surrounding injured players. As for Gonsolin, this opportunity could be a chance to prove his resilience and regain his place as a reliable starter in the MLB. The question remains whether he can overcome his recent health issues and deliver the performance that the Royals are hoping for.
In my opinion, the Royals' decision to sign Gonsolin is a strategic move that showcases their willingness to take calculated risks. It also demonstrates their commitment to building a strong and competitive team, even if it means dealing with the uncertainties surrounding injured players. As for Gonsolin, this opportunity could be a turning point in his career, allowing him to prove his resilience and regain his place as a reliable starter in the MLB. The coming months will be crucial in determining whether this move will pay off for both the Royals and Gonsolin himself.
